Table 3.

PAH adduct levels by genotype among controls, Long Island breast cancer study project, 1996-1997

GenotypeNondetectable PAH levelsDetectable PAH levelsAdjusted OR* (95% CI)
ERCC1
    CC1513561.00
    CA1192581.07 (0.80-1.43)
    AA20301.60 (0.88-2.91)
XPA
    GG1302781.00
    GA1242760.97 (0.72-1.31)
    AA37870.92 (0.59-1.43)
XPD
    GG1332791.00
    GA1092760.82 (0.61-1.11)
    AA44781.19 (0.77-1.82)
XPF
    GG2375201.00
    GA+AA451090.92 (0.63-1.34)
XPG
    GG1633291.00
    GC972550.76 (0.56-1.03)
    CC19390.93 (0.52-1.67)
  • * Adjusted for age and smoking status.